Journal article icon

Journal article

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark

Abstract:

Summary: Bisphosphonates are contraindicated in moderate-to-severe chronic kidney disease patients. However, they are used to prevent fragility fractures in patients with impaired kidney function, despite a lack of evidence on their effects on bone density in these patients. We demonstrated that Alendronate had a positive effect on bone in these patients.

Purpose: This study aimed to assess the association between alendronate use and bone ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s11657-020-00746-z

Authors


Expand authors...
Publisher:
Springer Publisher's website
Journal:
Archives of Osteoporosis Journal website
Volume:
15
Article number:
81
Publication date:
2020-06-01
Acceptance date:
2020-04-30
DOI:
EISSN:
1862-3514
ISSN:
1862-3522
Language:
English
Keywords:
Pubs id:
1102721
Local pid:
pubs:1102721
Deposit date:
2020-05-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP